New pill shows promise for Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial tests an oral tablet called BB102 in people with advanced solid tumors that have not responded to standard treatments. The drug targets a specific protein (FGFR4) that may help control cancer growth. The study will check safety, side effects, and how the dr…
Phase: PHASE1 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC